Kelly D L, Rizzino A
Eppley Institute for Cancer Research, University of Nebraska Medical Center, Omaha 68198-6805, USA.
Anticancer Res. 1999 Nov-Dec;19(6A):4791-807.
It is widely recognized that growth factors play critical roles in cell proliferation and differentiation. In the early 1980s, several members of the transforming growth factor-beta (TGF-beta) superfamily were identified and subsequently shown to play important roles in many diseases, in particular cancer. Efforts to understand how TGF-beta exerts its effects led to identification of TGF-beta-receptors and several downstream signaling pathways activated by this family of growth factors. This review provides an overview of TGF-beta-receptors and its downstream signaling pathways. As part of this discussion, this review indicates that inactivation of TGF-beta-receptors or components of their signaling pathways is often a target during carcinogenesis and that mutations or altered expression at any step along this complex, growth regulatory pathway can lead to aberrant cell proliferation. Lastly, the Cancer Genome Anatomy Project is briefly discussed, in particular how it may help to identify aberrant growth factor expression during carcinogenesis and improve the diagnosis of cancer patients.
人们普遍认识到生长因子在细胞增殖和分化中发挥着关键作用。20世纪80年代初,转化生长因子-β(TGF-β)超家族的几个成员被鉴定出来,随后被证明在许多疾病,尤其是癌症中发挥重要作用。为了解TGF-β如何发挥其作用所做的努力导致了TGF-β受体以及该生长因子家族激活的几个下游信号通路的鉴定。本综述概述了TGF-β受体及其下游信号通路。作为本次讨论的一部分,本综述指出TGF-β受体或其信号通路成分的失活通常是致癌过程中的一个靶点,并且沿着这条复杂的生长调节通路的任何步骤发生的突变或表达改变都可能导致异常的细胞增殖。最后,简要讨论了癌症基因组解剖计划,特别是它如何有助于识别致癌过程中异常的生长因子表达并改善癌症患者的诊断。